A Phase I, Blinded, Randomized Study of Nebulized RNS60 Combination With Budesonide in Adult Healthy Subjects and Patients With Mild to Moderate Chronic Asthma.

Trial Profile

A Phase I, Blinded, Randomized Study of Nebulized RNS60 Combination With Budesonide in Adult Healthy Subjects and Patients With Mild to Moderate Chronic Asthma.

Completed
Phase of Trial: Phase I

Latest Information Update: 04 Mar 2014

At a glance

  • Drugs RNS 60 (Primary) ; Budesonide
  • Indications Asthma
  • Focus Adverse reactions
  • Most Recent Events

    • 04 Mar 2014 Results presented at the 70th Annual Meeting of the American Academy of Allergy, Asthma and Immunology.
    • 11 Jan 2012 Actual end date (Jan 2011) added as reported by ClinicalTrials.gov.
    • 11 Jan 2012 Actual patient number is 36 according to ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top